To ask the Secretary of State for Health what recent discussions he has had on (a) the number of treatment options available as a first line to patients with advanced melanoma and (b) the clinical effectiveness of the treatment options available as a first line to patients with advanced melanoma; and if he will make a statement.

We have had no recent discussions on these issues but drug options for the first-line treatment of advanced melanoma were raised by my hon. Friend Pauline Latham during oral questions on 25 February 2014, Hansard, column 159 and during a debate in Westminster Hall on Cancer Treatment and Prevention on 11 March 2014, Hansard, column 38WH.